[ad_1]
Original title: State Administration of Traditional Chinese Medicine: Multiple Joint Departments to Strengthen Management on the Source of Chinese Medicinal Materials
China News Service, March 29. Li Yu, Director of the Department of Science and Technology of the State Administration of Traditional Chinese Medicine, pointed out on 29 that during the period of the “XIV Five-Year Plan”, the State Administration of Traditional Chinese Medicine will cooperate with the Ministry of Agriculture and Rural Affairs, the State Administration of Medicines, the Ministry of Industry and Information Technology and market supervision. The General Administration and other relevant departments will work together to strengthen the management of the Chinese medicinal materials germplasm source, strengthen the management of the entire process of planting, industrial production and circulation of Chinese medicinal materials, implement the quality improvement project of authentic Chinese medicinal materials and improve the standardized planting level of Chinese medicinal materials.
The Information Office of the State Council held a press conference on the 29th to present the in-depth implementation of the “14th Five-Year Plan” and promote the development of traditional Chinese medicine, and answer questions from journalists. A reporter asked that with the increasing demand for public health, my country’s TCM industry is developing rapidly, but to some extent, there is not enough high-quality supply. How to further increase production and quality during the “14th Five-Year Plan” period to promote the development of the TCM industry? On the other hand, in recent years, the number of new Chinese drugs approved for commercialization is relatively small, which is related to the inconsistency of the review standards of new drugs of the past with the characteristics of traditional Chinese drugs. How to establish a review and approval mechanism that meets the characteristics of traditional Chinese medicine during the period of the “XIV Five-Year Plan”?
“The quality of Chinese medicine is related to the clinical efficacy of Chinese medicine, and it is also related to the development of Chinese medicine and the high-quality development of the Chinese medicine industry. The main comrades of the central government are very concerned, all sectors of society are also very concerned, and people are also very concerned. ” Li Yu noted: “Fourteenth During the” Five “period, the State Administration of Traditional Chinese Medicine will work with the Ministry of Agriculture and Rural Affairs, the State Food and Drug Administration, the Ministry of Industry and Information Technology, the Administration State Market Supervision and other relevant departments to strengthen the management of Chinese medicinal materials germplasm sources and strengthen the cultivation, industrial production and circulation of Chinese medicines Materials. Process management, implement the quality improvement project of authentic Chinese medicinal materials, improve the standardized planting level of Chinese medicinal materials, improve the construction of the Chinese medicinal materials inspection and testing system, strengthen the quality risk assessment and risk monitoring of Chinese materials medicinal materials, and serve the mat Chinese medicinal wasteland, Chinese medicine industry and circulation industry.High-quality development provides better support, so that people can use traditional Chinese medicine with confidence.
Li Yu said that the State Administration of Traditional Chinese Medicine will cooperate with the State Administration of Traditional Chinese Medicine to continue to improve the reform of examination and approval of Chinese medicines in terms of review and approval of Chinese medicines and the development of new medicines, in order to to promote the research and development of new Chinese medicines and the development of the Chinese medicine industry.
The first is to adhere to the values-oriented clinical approach, promote the establishment of efficacy evaluation standards that are consistent with the clinical positioning of TCM and reflect its characteristics and benefits, and encourage efficacy evaluation focused on the patient.
The second is to promote the development of ancient classical famous recipes and compound preparations of traditional Chinese medicine, organize research and formulate key information research opinions on ancient classical famous recipes, establish a revision model that is compatible with the characteristics of the old and traditional classic famous recipes. Chinese medicine compound preparations and simplify approval procedures.
The third is to build a “three-in-one” review testing system. Attach importance to the supporting role of “human experience” in the safety and efficacy of TCM, and build an evaluation test system that combines TCM theory, “human experience”, and clinical trials. in accordance with the characteristics, laws and practice of TCM The era of TCM heritage and development of innovation provides a broader platform and path.
(Source: China News Network)
(Editor in charge: DF398)
I solemnly declare: The purpose of this information disclosed by Oriental Fortune.com is to spread more information and has nothing to do with this booth.
[ad_2]